Uniclophen eye drops 0.1%, 5 ml — Made in Slovakia — Free Delivery

Product description

The preparation "Uniclophen" is used for the following indications:

• inhibition of the development of intraoperative miosis during cataract surgery (Uniclophen does not have characteristic mydriatic properties and does not replace standard preparations that cause pupil dilation);
• treatment of postoperative inflammatory process after cataract removal and other surgical interventions;
• control of the severity of pain and discomfort in ophthalmology associated with damage to the corneal epithelium after excimer photorefractive therapy (PRK) or minor non-penetrating trauma;
• control of the development of the inflammatory process after argon laser trabeculoplasty (ALT);
• reducing the signs and symptoms of seasonal allergic conjunctivitis (SAK) in ophthalmology;
• treatment of inflammation and discomfort after surgical treatment of strabismus;
• treatment of pain and discomfort in ophthalmology after radial keratotomy.

Structure

The active ingredient is diclofenac sodium (1 ml of solution contains 1 mg of diclofenac sodium).

Excipients: boric acid, sodium tetraborate, propylene glycol, hydroxypropyl betadex, disodium edetate, benzalkonium chloride, water for injection.

1 ml contains 30 drops.

Contraindications

Hypersensitivity to the active substance or other components of the preparation.

Like other non-steroidal anti-inflammatory preparations (NSAIDs), "Uniclophen" is contraindicated in patients with attacks of bronchial asthma, urticaria, acute rhinitis associated with the use of acetylsalicylic acid or other preparations that inhibit the activity of prostaglandin synthetase. There is a possibility of cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives and other NSAIDs.

Intraocular administration of the preparation  during a surgical procedure.

Mode of application

This medication is intended only for instillation into the conjunctival sac of the eye. In no case should it be administered subconjunctivally, nor should it be injected directly into the anterior chamber of the eye.

Recommended dosages:

• prevention of intraoperative miosis - one drop 4 times within 2 hours before surgery;
• control of the development of the inflammatory process in the postoperative period - one drop 4 times a day for a period of up to 28 days;
• control of the severity of pain and discomfort in the period after the PRK - one drop 2 times per hour before the operation, one drop 2 times within 5 minutes immediately after the PRK, and then in the postoperative period, one drop every 2 5 hours during the waking period for 24 hours;
• control of the severity of pain in ophthalmology associated with damage to the corneal epithelium after a minor non-penetrating injury - one drop 4 times a day for 2 days;
• control of the development of the inflammatory process after ALT: one drop 4 times within 2 hours before ALT, and then one drop 4 times a day for 7 days;
• reduction of signs and symptoms of seasonal allergic conjunctivitis in ophthalmology - one drop 4 times a day for as long as necessary;
• treatment of inflammation and discomfort after surgical treatment of strabismus - one drop 4 times a day for the 1st week, 3 times a day for the 2nd week, 2 times a day for the 3rd week and, if necessary, in during the 4th week;
• treatment of pain and discomfort in ophthalmology after radial keratotomy: in the preoperative period - one drop before the operation, in the postoperative period - one drop immediately after the operation, and then one drop 4 times a day for a period of up to 2 days.

Application features

Pregnant

I and II trimester of pregnancy: studies conducted in animals did not reveal a risk to the fetus, but there were no controlled studies with the participation of pregnant women.

It should not be used during the third trimester due to the possible risk of premature closure of the ductus arteriosus and possible suppression of labor pains.

Diclofenac is excreted in breast milk. However, the effect of the preparation "Uniclophen" in therapeutic doses on a breastfed baby is not expected. The use of diclofenac in ophthalmology is not recommended during breastfeeding, except when the expected benefit from the use of the preparation outweighs the possible risk.

Children

Do not use the preparation in children. Experience with the preparation in this age group is limited by the few published clinical studies conducted in the field of strabismus surgery.

Drivers

Patients who have blurred vision should refrain from driving and working with mechanisms.

Overdose

There is practically no risk of side effects due to accidental ingestion, since the 5 ml vial with eye drops contains only 5 mg of diclofenac sodium, which corresponds to about 3% of the recommended maximum daily dose of the preparation "Uniclofen" for adults after oral administration.

Side effects

From the side of the eyes: often (≥ 1/100 to <1/10) - speckled keratitis, eye pain, irritation of the mucous membrane of the eyes, itching, conjunctival hyperemia.

Storage conditions

Store in its original packaging at a temperature not exceeding 25 ° C, out of the reach of children. Do not freeze.

Shelf life is 2 years.

Store no more than 28 days after opening.